Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromelain in inflammatory bowel disease
IRCT20191105045340N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2023
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of bromelain in Crohn's disease, autoimmune colitis and inflammatory bowel disease (IBD), sponsored by Iran University of Medical Sciences. Started Aug 2023; status: completed.
02
Drugs
bromelain
03
Conditions
Crohn's diseaseautoimmune colitisinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on IRCT20191105045340N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191105045340N2.